Research tools
Analyst Ratings Screener
Find recent upgrades, downgrades, initiations, and reiterations by firm, rating, consensus, target upside, sector, and company size.
Save your best screens
Sign in to keep filters and sorting ready for your next visit.
4,341 matching rating changes
Export CSV| Date, sort lowest first | Symbol | Company | Firm | Action | Prior rating | New rating | Consensus | Analysts, sort highest first | Avg. target | Target upside, sort highest first | Market cap, sort highest first |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | BLTE | Belite Bio, Inc | Mizuho | Main | Outperform | Outperform | — | — | $191.50 | +9.38% | 5.24B |
| Sep 9, 2026 | BNED | Barnes & Noble Education, Inc. | Needham | Reiterated | Buy | Buy | — | — | $2.38 | -78.21% | 311.42M |
| Sep 9, 2026 | BRKR | Bruker Corporation | UBS | Main | Neutral | Neutral | Buy | 20 | $49.71 | -7.19% | 7.04B |
| Sep 9, 2026 | BRKRP | Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A | UBS | Main | Neutral | Neutral | Buy | 12 | — | — | 54.39B |
| Sep 9, 2026 | BRZE | Braze, Inc. | JP Morgan | Main | Overweight | Overweight | — | — | $44.63 | +83.93% | 3.71B |
| Sep 9, 2026 | BRZE | Braze, Inc. | Canaccord Genuity | Main | Buy | Buy | — | — | $44.63 | +83.93% | 3.71B |
| Sep 9, 2026 | BRZE | Braze, Inc. | UBS | Main | Buy | Buy | — | — | $44.63 | +83.93% | 3.71B |
| Sep 9, 2026 | BRZE | Braze, Inc. | Citizens | Reiterated | Market Outperform | Market Outperform | — | — | $44.63 | +83.93% | 3.71B |
| Sep 9, 2026 | BRZE | Braze, Inc. | Needham | Reiterated | Buy | Buy | — | — | $44.63 | +83.93% | 3.71B |
| Sep 9, 2026 | BRZE | Braze, Inc. | Stephens & Co. | Main | Overweight | Overweight | — | — | $44.63 | +83.93% | 3.71B |
| Sep 9, 2026 | BRZE | Braze, Inc. | BTIG | Reiterated | Buy | Buy | — | — | $44.63 | +83.93% | 3.71B |
| Sep 9, 2026 | BRZE | Braze, Inc. | Piper Sandler | Reiterated | Overweight | Overweight | — | — | $44.63 | +83.93% | 3.71B |
| Sep 9, 2026 | BRZE | Braze, Inc. | DA Davidson | Main | Buy | Buy | — | — | $44.63 | +83.93% | 3.71B |
| Sep 9, 2026 | BRZE | Braze, Inc. | Raymond James | Main | Outperform | Outperform | — | — | $44.63 | +83.93% | 3.71B |
| Sep 9, 2026 | BSX | Boston Scientific Corporation | BTIG | Main | Buy | Buy | Buy | 24 | $127.00 | +194.66% | 135.98B |
| Sep 9, 2026 | BXP | BXP, Inc. | Truist Securities | Main | Hold | Hold | Hold | 27 | $80.17 | +25.82% | 11.35B |
| Sep 9, 2026 | CAI | Caris Life Sciences, Inc. | UBS | Initiated | — | Neutral | Buy | 12 | $35.00 | +45.59% | 7.49B |
| Sep 9, 2026 | CAN | Canaan Inc. | BTIG | Main | Buy | Buy | — | — | $2.92 | +845.90% | 416.4M |
| Sep 9, 2026 | CAN | Canaan Inc. | Rosenblatt | Main | Buy | Buy | — | — | $2.92 | +845.90% | 416.4M |
| Sep 9, 2026 | CASY | Casey's General Stores, Inc. | Wells Fargo | Main | Overweight | Overweight | Buy | 20 | $585.67 | -6.69% | 20.15B |
| Sep 9, 2026 | CASY | Casey's General Stores, Inc. | Stephens & Co. | Reiterated | Overweight | Overweight | Buy | 20 | $585.67 | -6.69% | 20.15B |
| Sep 9, 2026 | CASY | Casey's General Stores, Inc. | RBC Capital | Main | Sector Perform | Sector Perform | Buy | 20 | $585.67 | -6.69% | 20.15B |
| Sep 9, 2026 | CCG | Cheche Group Inc. | Maxim Group | Downgrade | Buy | Hold | Buy | 5 | — | — | 79.49M |
| Sep 9, 2026 | CHYM | Chime Financial, Inc. Class A Common Stock | Scotiabank | Main | Sector Outperform | Sector Outperform | — | — | $30.40 | -6.95% | 10.3B |
| Sep 9, 2026 | CHYM | Chime Financial, Inc. Class A Common Stock | Loop Capital | Initiated | — | Buy | — | — | $30.40 | -6.95% | 10.3B |
| Sep 9, 2026 | CHYM | Chime Financial, Inc. Class A Common Stock | Morgan Stanley | Main | Overweight | Overweight | — | — | $30.40 | -6.95% | 10.3B |
| Sep 9, 2026 | CHYM | Chime Financial, Inc. Class A Common Stock | Piper Sandler | Main | Overweight | Overweight | — | — | $30.40 | -6.95% | 10.3B |
| Sep 9, 2026 | CHYM | Chime Financial, Inc. Class A Common Stock | Barclays | Main | Overweight | Overweight | — | — | $30.40 | -6.95% | 10.3B |
| Sep 9, 2026 | CHYM | Chime Financial, Inc. Class A Common Stock | Keybanc | Main | Overweight | Overweight | — | — | $30.40 | -6.95% | 10.3B |
| Sep 9, 2026 | CHYM | Chime Financial, Inc. Class A Common Stock | Canaccord Genuity | Main | Buy | Buy | — | — | $30.40 | -6.95% | 10.3B |
| Sep 9, 2026 | CHYM | Chime Financial, Inc. Class A Common Stock | Evercore ISI Group | Main | Outperform | Outperform | — | — | $30.40 | -6.95% | 10.3B |
| Sep 9, 2026 | CHYM | Chime Financial, Inc. Class A Common Stock | UBS | Main | Neutral | Neutral | — | — | $30.40 | -6.95% | 10.3B |
| Sep 9, 2026 | CMC | Commercial Metals Company | JP Morgan | Main | Overweight | Overweight | Hold | 17 | $68.20 | +2.37% | 7.92B |
| Sep 9, 2026 | CNS | Cohen & Steers, Inc. | Evercore ISI Group | Main | Outperform | Outperform | Sell | 10 | $87.50 | +14.14% | 3.2B |
| Sep 9, 2026 | COIN | Coinbase Global, Inc. | Goldman Sachs | Main | Buy | Buy | Buy | 24 | $391.47 | +127.23% | 68.84B |
| Sep 9, 2026 | COLL | Collegium Pharmaceutical, Inc. | Leerink Partners | Initiated | — | Outperform | — | — | $58.00 | +153.05% | 1.53B |
| Sep 9, 2026 | COLL | Collegium Pharmaceutical, Inc. | Truist Securities | Main | Buy | Buy | — | — | $58.00 | +153.05% | 1.53B |
| Sep 9, 2026 | CRH | CRH plc | Wells Fargo | Main | Overweight | Overweight | Buy | 13 | $136.60 | +55.83% | 85.13B |
| Sep 9, 2026 | CRI | Carter's, Inc. | BMO Capital | Initiated | — | Outperform | — | — | $27.50 | -8.91% | 1.21B |
| Sep 9, 2026 | CRK | Comstock Resources, Inc. | UBS | Main | Sell | Sell | — | — | $15.50 | +2.04% | 6.3B |
| Sep 9, 2026 | CXT | Crane NXT, Co. | DA Davidson | Main | Buy | Buy | — | — | $80.00 | +58.82% | 3.13B |
| Sep 9, 2026 | DASH | DoorDash, Inc. | Scotiabank | Initiated | — | Sector Outperform | Buy | 31 | $298.00 | +48.24% | 96.78B |
| Sep 9, 2026 | DECK | Deckers Outdoor Corporation | BMO Capital | Initiated | — | Underperform | — | — | $115.64 | +44.77% | 15.19B |
| Sep 9, 2026 | DEI | Douglas Emmett, Inc. | JP Morgan | Main | Neutral | Neutral | — | — | $15.00 | +40.58% | 1.97B |
| Sep 9, 2026 | DELL | Dell Technologies Inc. | Evercore ISI Group | Main | Outperform | Outperform | Buy | 19 | $161.75 | -68.08% | 93.2B |
| Sep 9, 2026 | DKS | DICK'S Sporting Goods, Inc. | BMO Capital | Initiated | — | Underperform | — | — | $239.64 | +79.99% | 17.55B |
| Sep 9, 2026 | DYN | Dyne Therapeutics, Inc. | Baird | Main | Outperform | Outperform | — | — | $38.11 | +106.89% | 2.77B |
| Sep 9, 2026 | DYN | Dyne Therapeutics, Inc. | RBC Capital | Main | Outperform | Outperform | — | — | $38.11 | +106.89% | 2.77B |
| Sep 9, 2026 | EBS | Emergent BioSolutions Inc. | HC Wainwright & Co. | Reiterated | Buy | Buy | — | — | $51.50 | +777.34% | 633.13M |
| Sep 9, 2026 | EFSI | Eagle Financial Services, Inc. | DA Davidson | Main | Neutral | Neutral | — | — | $40.00 | -12.40% | 213.17M |
